Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
Research output
Search by expertise, name or affiliation
Macrocyclic peptide inhibitors of viral fusion proteins
Vito Thijssen
Afd Chemical Biology and Drug Discovery
Chemical Biology and Drug Discovery
Research output
:
Thesis
›
Doctoral thesis 1 (Research UU / Graduation UU)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Macrocyclic peptide inhibitors of viral fusion proteins'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Virus
100%
Viral Fusion Protein
100%
Peptide Inhibitor
100%
Macrocyclic Peptides
100%
RaPID System
100%
Antiviral Drugs
50%
Cyclic Peptide
50%
Hemagglutinin Protein
50%
Glycoprotein
25%
Spike Protein
25%
Process Optimization
25%
Selection Strategy
25%
Clinical Potential
25%
Drug Development
25%
Resistance Mechanisms
25%
Influenza A
25%
Selection Mechanism
25%
H5 Subtype
25%
Optimization Techniques
25%
System Effectiveness
25%
Broad-spectrum Inhibitor
25%
Protein-peptide Complexes
25%
In Vitro Translation
25%
New Antivirals
25%
Antiviral Resistance
25%
Pandemic Virus
25%
Pandemic Outbreak
25%
Peptide Selection
25%
Peptide Targeting
25%
Multiple Variants
25%
Continuous Updating
25%
Viral mutation
25%
COVID-19
25%
Protein-resistant
25%
Hemagglutinin Stem
25%
Innovative Approach
25%
H1 Subtypes
25%
Iterative Selection
25%
Emerging Drug Resistance
25%
Cyclic Peptoids
25%
Biochemistry, Genetics and Molecular Biology
Hemagglutinin
100%
Chimeric Protein
100%
Cyclic Peptide
100%
Glycoprotein
33%
Virus Resistance
33%
SARS Coronavirus
33%
Spike
33%
Process Optimization
33%
Drug Resistance
33%
Messenger RNA
33%